Biodistribution, Clearance And Morphological Alterations Of Intravenously Administered Iron Oxide Nanoparticles In Male Wistar Rats

References

• Oberdorster G, Maynard A, Donaldson K, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8. doi:10.1186/1743-8977-2-816209704
   PubMed Web of Science ®Google Scholar
• Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci. 2002;99:12617–12621. doi:10.1073/pnas.15246339912235356
   PubMed Web of Science ®Google Scholar
• Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 2004;15:79–86. doi:10.1021/bc034153y
   PubMed Web of Science ®Google Scholar
• Cagle DW, Kennel SJ, Mirzadeh S, Alford JM, Wilson LJ. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc Natl Acad Sci. 1999;96:5182–5187. doi:10.1073/pnas.96.9.518210220440
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912–1919. doi:10.1016/j.biomaterials.2007.12.03718242692
   PubMed Web of Science ®Google Scholar
• Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharm. 2011;258:151–165. doi:10.1016/j.taap.2011.11.010
   PubMed Web of Science ®Google Scholar
• Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. Evaluation ofiron oxide nanoparticle biocompatibility. Int J Nanomed. 2011;6:787–794. doi:10.2147/IJN.S17574
   PubMed Web of Science ®Google Scholar
• Singh SP, Rahman MF, Murty USN, Mahboob M, Grover P. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol Appl Pharm. 2013;266:56–66. doi:10.1016/j.taap.2012.10.016
   PubMed Web of Science ®Google Scholar
• Gu L, Fang RH, Sailor MJ, Park JH. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano. 2012;6:4947–4954. doi:10.1021/nn300456z22646927
   PubMed Web of Science ®Google Scholar
• Wang J, Chen Y, Chen B, et al. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int J Nanomed. 2010;21:861–866. doi:10.2147/IJN.S13662
   Google Scholar
• Wang L, Wang L, Ding W, Zhang F. Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats. J Nanosci Nanotechnol. 2010;10:8617–8624. doi:10.1166/jnn.2010.248321121374
   PubMed Web of Science ®Google Scholar
• Zhu MT, Feng WY, Wang B, et al. Comparative study of pulmonary responses to nano-and submicron-sized ferric oxide in rats. Toxicology. 2008;247:102–111. doi:10.1016/j.tox.2008.02.01118394769
   PubMed Web of Science ®Google Scholar
• Meng Z, Wei F, Ma W, et al. Design and synthesis of “all‐in‐one” multifunctional FeS2 nanoparticles for magnetic resonance and near‐infrared imaging guided photothermal therapy of tumors. Adv Funct Mater. 2016;26:8231–8242. doi:10.1002/adfm.201603776
   Web of Science ®Google Scholar
• Powers KW, Palazuelos M, Moudgil BM, Roberts SM. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology. 2007;1:42–51. doi:10.1080/17435390701314902
   Web of Science ®Google Scholar
• Randhawa MA. Calculation of LD50 values from the method of Miller and Tainter, 1944. J Ayub Med Coll Abbottabad. 2009;21:184–185.20929045
   PubMedGoogle Scholar
• Gaharwar US, Meena R, Rajamani P. Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes. J Appl Toxicol. 2017;37:1232–1244. doi:10.1002/jat.348528585739
   PubMed Web of Science ®Google Scholar
• Kateb B, Chiu K, Black KL, et al. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage. 2011;54:106–124. doi:10.1016/j.neuroimage.2010.01.105
   PubMed Web of Science ®Google Scholar
• Szebeni J. Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry. Neuropsychopharmacol Hungarica. 2011;13:15–24.
   PubMedGoogle Scholar
• Kumari M, Rajak S, Singh SP, et al. Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats. Drug Chem Toxicol. 2013;36:296–305. doi:10.3109/01480545.2012.72098823025823
   PubMed Web of Science ®Google Scholar
• Tiwari DK, Jin T, Behari J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Method. 2011;21:13–24. doi:10.3109/15376516.2010.529184
   PubMed Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol. 2010;7:20. doi:10.1186/1743-8977-7-2020691052
   PubMed Web of Science ®Google Scholar
• Souris JS, Lee CH, Cheng SH, et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 2010;31:5564–5574. doi:10.1016/j.biomaterials.2010.03.04820417962
   PubMed Web of Science ®Google Scholar
• Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol. 2007;49:217–229. doi:10.1016/j.yrtph.2007.07.00617868963
   PubMed Web of Science ®Google Scholar
• Neuberger T, Schöpf B, Hofmann H, Hofmann M, Von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater. 2005;293:483–496. doi:10.1016/j.jmmm.2005.01.064
   Web of Science ®Google Scholar
• Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, et al. Time‐dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol. 2012;32:920–928. doi:10.1002/jat.275822696427
   PubMed Web of Science ®Google Scholar
• Patri A, Umbreit T, Zheng J, et al. Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice. J Appl Toxicol. 2009;29:662–672. doi:10.1002/jat.145419626582
   PubMed Web of Science ®Google Scholar
• Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA. Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst. 2011;7:371–378. doi:10.1039/c0mb00109k20877915
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B. 2008;66:274–280. doi:10.1016/j.colsurfb.2008.07.004
   PubMed Web of Science ®Google Scholar
• Ren X, Zheng R, Fang X, et al. Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials. 2016;92:13–24. doi:10.1016/j.biomaterials.2016.03.02627031929
   PubMed Web of Science ®Google Scholar
• Wijnhoven SW, Peijnenburg WJ, Herberts CA, et al. Nano-silver–a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology. 2009;3:109–138. doi:10.1080/17435390902725914
   Web of Science ®Google Scholar
• Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm. 2008;5:316–327. doi:10.1021/mp700128518217714
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5:496–504. doi:10.1021/mp800049w18611037
   PubMed Web of Science ®Google Scholar
• Kumar R, Roy I, Ohulchanskky TY, et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;4:699–708. doi:10.1021/nn901146y20088598
   PubMed Web of Science ®Google Scholar
• Burns AA, Vider J, Ow H, et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2008;9:442–448. doi:10.1021/nl803405h
   Web of Science ®Google Scholar
• Schipper ML, Iyer G, Koh AL, et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small. 2009;5:126–134. doi:10.1002/smll.20080000319051182
   PubMed Web of Science ®Google Scholar
• Chen Z, Meng H, Xing G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006;163:109–120. doi:10.1016/j.toxlet.2005.10.00316289865
   PubMed Web of Science ®Google Scholar
• Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Enviro Health, Part A. 2009;72:1279–1284. doi:10.1080/15287390903212287
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou G, Chen C, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett. 2007;168:176–185. doi:10.1016/j.toxlet.2006.12.00117197136
   PubMed Web of Science ®Google Scholar
• Iversen NK, Frische S, Thomsen K, et al. Superparamagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol Appl Pharm. 2013;266:276–288. doi:10.1016/j.taap.2012.10.014
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. 2008;20:575–583. doi:10.1080/08958370701874663
   PubMed Web of Science ®Google Scholar
• Park EJ, Kim H, Kim Y, Choi K. Repeated-dose toxicity attributed to aluminum nanoparticles following 28-day oral administration, particularly on gene expression in mouse brain. Toxicol Environ Chem. 2011;93:120–133. doi:10.1080/02772248.2010.495191
   Web of Science ®Google Scholar
• Pujalté I, Passagne I, Brouillaud B, et al. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol. 2011;8:1–16. doi:10.1186/1743-8977-8-1021235812
   PubMed Web of Science ®Google Scholar
• Sarhan OMM, Hussein RM. Effects of intraperitoneally injected silver nanoparticles on histological structures and blood parameters in the albino rat. Int J Nanomed. 2014;9:1505. doi:10.2147/IJN.S56729
   PubMed Web of Science ®Google Scholar
• Wu F, Zhang M, Lu H, et al. Triple stimuli-responsive magnetic hollow porous carbon-based nanodrug delivery system for magnetic resonance imaging-guided synergistic photothermal/chemotherapy of cancer. ACS Appl Mater Interfaces. 2018;10:21939–21949. doi:10.1021/acsami.8b0721329893126
   PubMedGoogle Scholar
• Qian ZM, Chang YZ, Leung G, et al. Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart. Biochim Biophys Acta (BBA). 2007;1772:527–532. doi:10.1016/j.bbadis.2007.02.00617383861
   PubMedGoogle Scholar
• Barrefelt A, Saghafian M, Kuiper R, et al. Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat. Int J Nanomed. 2013;8:3241. doi:10.2147/IJN.S49948
   PubMed Web of Science ®Google Scholar
• Descamps L, Dehouck MP, Torpier G, Cecchelli R. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol Heart Circ Physiol. 1996;270:H1149–H1158. doi:10.1152/ajpheart.1996.270.4.H1149
   PubMed Web of Science ®Google Scholar
• Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van der Schyf CJ. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res. 2007;32:1196–1208. doi:10.1007/s11064-007-9290-417404839
   PubMed Web of Science ®Google Scholar
• Kiruba SCG, Tharmaraj V, Sironman TA, Pitchumani K. Toxicity and immunological activity of silver nanoparticles. Appl Clay Sci. 2010;48:547–551. doi:10.1016/j.clay.2010.03.001
   Web of Science ®Google Scholar
• Thakur M, Gupta H, Singh D, et al. Histopathological and ultra structural effects of nanoparticles on rat testis following 90 days (Chronic study) of repeated oral administration. J Nanobiotechnol. 2014;12:1–13. doi:10.1186/s12951-014-0042-8
   Web of Science ®Google Scholar
• Miresmaeili SM, Halvaei I, Fesahat F, Fallah A, Nikonahad N, Taherinejad M. Evaluating the role of silver nanoparticles on acrosomal reaction and spermatogenic cells in rat. Iran J Reprod Med. 2013;11:423.24639775
   PubMedGoogle Scholar
• Meena R, Kajal K, Paulraj R. Cytotoxic and genotoxic effects of titanium dioxide nanoparticles in testicular cells of male wistar rat. Appl Biochem Biotechnol. 2014;175:825–840. doi:10.1007/s12010-014-1299-y25344432
   PubMedGoogle Scholar
• Wang B, Feng WY, Wang M, et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res. 2007;118:233–243. doi:10.1007/BF0269808617916926
   PubMed Web of Science ®Google Scholar
• Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicol. 2007;230:90–104. doi:10.1016/j.tox.2006.11.002
   PubMed Web of Science ®Google Scholar